Centenial Surgical Suture Ltd. (BOM:531380)

India · Delayed Price · Currency is INR

97.05

0.00 (0.00%)

At close: Sep 15, 2026

Market Cap	354.07M -6.9%
Revenue (ttm)	562.47M +6.7%
Net Income	-14.30M
EPS	-3.89
Shares Out	3.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	101.85
Previous Close	97.05
Day's Range	97.05 - 101.85
52-Week Range	73.04 - 124.90
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Centenial Surgical Suture

Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, ... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 1995

Employees 266

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531380

Full Company Profile

Financial Performance

In fiscal year 2026, Centenial Surgical Suture's revenue was 538.40 million, an increase of 0.61% compared to the previous year's 535.16 million. Losses were -22.05 million, 50.6% more than in 2025.

Financial Statements